CLB · TickerCove

CLBCore Laboratories N.V.Energy · Oil & Gas Equipment & Servicesas of 2026-09-16

Horizon

Issued 2026-09-16 at $11.45 · now $11.45 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, CLB has typically landed between $9.05 and $14.06 — a range of −20.9% to +22.8% from the issuance price $11.45.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($11.45) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$11.45 · 16% of range

$9.86 low$19.63 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−1.4%

typical move · IQR 18.9%

−20.9%worst (p90)+22.8%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where CLB has typically landed a month from the 2026-09-16 close of $11.45 — the range is history, not a prediction.

now $11.45 (+0.0%)
typical $11.29 (-1.4%)
middle 50% $10.21–$12.37
90% range $9.05–$14.06

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,003 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2020-02-14	−76.3%	−76.3%	+0.0%
2020-02-11	−76.1%	−76.1%	+0.4%
2020-02-18	−75.6%	−75.8%	+0.0%
3 best
2020-03-30	+107.2%	−0.2%	+107.2%
2020-04-02	+92.5%	+0.0%	+104.2%
2020-03-31	+89.6%	−8.2%	+90.6%

5,003 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

50%

+3.4%

n=20

Feb

55%

+1.2%

n=20

Mar

60%

−1.3%

n=20

Apr

55%

+5.8%

n=20

May

45%

+0.5%

n=20

Jun

65%

+0.5%

n=20

Jul

25%

−1.7%

n=20

Aug

55%

−1.9%

n=20

Sep

50%

−1.5%

n=20

Oct

50%

+1.6%

n=20

Nov

50%

+2.6%

n=20

Dec

45%

−1.3%

n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-07-31	Bruno Lawrence	director	Purchase	5,000 @ $10.78	$54K	+1.9% of holding	+14.3%	not yet — horizon still open	262,438	Form 4 · filed 4 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

109 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-08-01	Teo Sow Hang	officer	Withheld for tax	108	8,667	Form 4
2026-08-01	Tattoli Mark Damian	officer	Withheld for tax	99	27,665	Form 4
2026-08-01	Teo Sow Hang	officer	Withheld for tax	90	8,535	Form 4
2026-08-01	Teo Sow Hang	officer	Option exercise	240	6,250	Form 4
2026-08-01	Teo Sow Hang	officer	Option exercise	200	6,490	Form 4
2026-08-01	Teo Sow Hang	officer	Option exercise	240	8,775	Form 4
2026-08-01	Teo Sow Hang	officer	Option exercise	200	8,625	Form 4
2026-08-01	Tattoli Mark Damian	officer	Option exercise	250	27,764	Form 4
2026-08-01	Tattoli Mark Damian	officer	Option exercise	250	950	Form 4
2026-05-01	Tattoli Mark Damian	officer	Withheld for tax	97	27,514	Form 4
2026-05-01	Tattoli Mark Damian	officer	Option exercise	250	27,611	Form 4
2026-05-01	Tattoli Mark Damian	officer	Option exercise	250	1,200	Form 4
2026-04-01	Temeng Kwaku	director	Award / grant	7,895	7,895	Form 4
2026-04-01	Temeng Kwaku	director	Option exercise	8,069	0	Form 4
2026-04-01	Murray Katherine	director	Option exercise	8,069	0	Form 4
2026-04-01	Murray Katherine	director	Option exercise	8,069	29,290	Form 4
2026-04-01	Murray Katherine	director	Award / grant	7,895	7,895	Form 4
2026-04-01	Carnes Martha Z.	director	Option exercise	8,069	54,397	Form 4
2026-04-01	MARTINOVICH ROBERT F	director	Award / grant	7,895	7,895	Form 4
2026-04-01	Klingensmith Harvey Robert	director	Option exercise	8,069	50,031	Form 4
2026-04-01	Klingensmith Harvey Robert	director	Award / grant	7,895	7,895	Form 4
2026-04-01	Klingensmith Harvey Robert	director	Option exercise	8,069	0	Form 4
2026-04-01	ANASTASIO CURT	director	Option exercise	8,069	23,805	Form 4
2026-04-01	ANASTASIO CURT	director	Award / grant	7,895	7,895	Form 4
2026-04-01	ANASTASIO CURT	director	Option exercise	8,069	0	Form 4
2026-04-01	Carnes Martha Z.	director	Award / grant	7,895	7,895	Form 4
2026-04-01	Carnes Martha Z.	director	Option exercise	8,069	0	Form 4
2026-04-01	MARTINOVICH ROBERT F	director	Option exercise	8,069	8,069	Form 4
2026-04-01	MARTINOVICH ROBERT F	director	Option exercise	8,069	0	Form 4
2026-04-01	Temeng Kwaku	director	Option exercise	8,069	33,597	Form 4
2026-02-12	Gresham Gwendolyn	officer	Award / grant	33,490	33,490	Form 4
2026-02-12	Teo Sow Hang	officer	Award / grant	7,526	7,526	Form 4
2026-02-12	Hill Christopher Scott	officer	Award / grant	70,008	70,008	Form 4
2026-02-12	Tattoli Mark Damian	officer	Award / grant	33,490	33,490	Form 4
2026-02-12	Bruno Lawrence	director	Award / grant	204,340	204,340	Form 4
2025-12-31	Bruno Lawrence	director	Withheld for tax	112,681	257,438	Form 4
2025-12-31	Hill Christopher Scott	officer	Withheld for tax	32,152	110,202	Form 4
2025-12-31	Gresham Gwendolyn	officer	Withheld for tax	19,301	33,226	Form 4
2025-12-31	Tattoli Mark Damian	officer	Withheld for tax	14,310	27,361	Form 4
2025-12-31	Hill Christopher Scott	officer	Option exercise	61,417	142,354	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i